Sector: MedicalValeant Pharmaceuticals International (NYSE: VRX)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 9 |
Technical : | 230 |
Performance : | 164 |
Overall: | 122 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 9 |
Technical : | 241 |
Performance : | 166 |
Overall: | 137 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 8 |
Technical : | 235 |
Performance : | 159 |
Overall: | 124 |
Number of Stocks: | 305 |
Headlines
- CED Sets Dates For Upcoming Conference Season
Nov 03, 2009 12:01 PM | GSK, TRGT, VRX
- Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting
Nov 03, 2009 08:03 AM | VRX
- Meda: Retigabine Filings Completed in the US and Europe
Nov 02, 2009 08:18 AM | GSK, VRX
- Valeant Pharmaceuticals Reports Third Quarter Financial Results
Nov 02, 2009 08:02 AM | VRX
- Valeant to Acquire Polish Products
Oct 30, 2009 08:01 AM | VRX
- Valeant Pharmaceuticals to Announce 2009 Third Quarter Results on November 2, 2009
Oct 23, 2009 04:30 PM | VRX
- Medivation Names Hank Mansbach, M.D., Vice President of Medical Affairs
Oct 23, 2009 08:01 AM | MDVN, VRX
- New Study Assesses Skin Hydration and Epidermal Function of 2.5% and 5% Benzoyl Peroxide-Clindamycin Combinations
Oct 20, 2009 08:00 AM | VRX
- Valeant to Acquire Major Australian Skincare Brands
Sep 30, 2009 08:02 AM | VRX
- Valeant Buys-Out Rights to All Current and Future Income and Milestone Obligations From Former Dow Stockholders
Sep 29, 2009 08:02 AM | VRX
- State of the Art Electric Car Charging Stations Coming to Contra Costa County
Apr 04, 2009 12:51 PM | LSE, VRX
- Electric Car Sparking Back to Life: Once Declared Dead, the Electric Car Returns. Automakers Have Them in the Works, and the Zippy Tesla Leads the Way.
Mar 23, 2009 09:55 AM | DNA, GM, GOOG, LSE, MSBHY, MSFT
- Sparking Back to Life: Once Declared Dead, the Electric Car Returns. Automakers Have Them in the Works, and the Zippy Tesla Leads the Way.
Mar 23, 2009 03:59 AM | DNA, GM, GOOG, LSE, MSBHY, MSFT
- Electric Dreams: Slick Cycle Offers an Ecofriendly Alternative
Mar 17, 2009 10:57 AM | LSE, VRX
- Coria Laboratories Launches Acanya(TM) Gel
Mar 06, 2009 01:02 PM | VRX
- '08 Blade Stock Contest Leaves Only 5 Entrants in the Black
Jan 11, 2009 02:20 PM | AKNS, AMD, AMGN, AMKR, DNDN, EBS
- First All-Electric Scooters Charging Charlotte Market
Aug 14, 2008 08:52 PM | LSE, VRX
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on VRX, BBV, GMR, PRE, DB and PZE
Sep 29, 2009 07:10 AM | BBV, DB, GMR, PRE, PZE, VRX
- Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
Aug 24, 2009 08:01 AM | VRX
- Valeant Pharmaceuticals Reports Second Quarter Financial Results
Aug 04, 2009 08:02 AM | VRX
- Valeant to Acquire Tecnofarma, A Mexican Generic Company
Jul 29, 2009 08:07 AM | VRX
- Valeant Pharmaceuticals to Announce 2009 Second Quarter Results on August 4, 2009
Jul 21, 2009 04:30 PM | VRX
- Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(R) ER in Canada, Australia and New Zealand; Agreement Demonstrates Value of OPANA ER in Markets Outside U.S.
Jun 09, 2009 08:02 AM | NVS, PPCO, VRX
- Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
Jun 09, 2009 07:31 AM | ENDP, PPCO, VRX
- Valeant Announces Pricing of Senior Notes
Jun 04, 2009 08:02 AM | VRX
- Valeant Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference
Jun 02, 2009 08:04 AM | VRX
- Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
Jun 01, 2009 08:15 AM | VRX
- Form 4 STEFANO STEPHEN F. For: Nov 04 (10K)
Nov 04, 2009 06:26 PM
- Form 4 STEFANO STEPHEN F. For: Oct 01 (10K)
Oct 05, 2009 08:06 PM
- Form 4 Provencio Norma Ann For: Oct 01 (10K)
Oct 05, 2009 08:06 PM
- Form 4 MELAS KYRIAZI THEO For: Oct 01 (10K)
Oct 05, 2009 08:04 PM
- Form 4 LONNER ANDERS For: Oct 01 (10K)
Oct 05, 2009 08:04 PM
- Form 4 KUGELMAN LARRY For: Oct 01 (10K)
Oct 05, 2009 08:03 PM
- Form 4 VALEANT PHARMACEUTICALS For: Oct 01 Filed by: KOPPES RICHARD (10K)
Oct 05, 2009 08:03 PM
- Form 4 DE SILVA RAJIV For: Sep 10 (10K)
Sep 14, 2009 04:36 PM
- Form 4 CHAUDHURI BHASKAR For: Sep 10 (10K)
Sep 14, 2009 04:36 PM
- Form 4 STEFANO STEPHEN F. For: Sep 04 (10K)
Sep 08, 2009 03:56 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
VRX
|
Compare to S&P
|
| YTD |
28.38 %
|
11.91 %
|
| 4 Weeks |
9.46 %
|
8.30 %
|
| 12 Weeks |
11.87 %
|
9.10 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 10.87 %
|
|
EPS Growth in Last Year: 950.00 %
|
|
Sales Growth in Last Quarter: 7.74 %
|
|
Sales Growth in Last Quarter: -7.29 %
|
|
